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OUTLINE
Name: Shanice Clarke
Section: 1
My topic: Bifidobacterium
I am very intrigue about microorganism and their association with living and non-living
organism. I decided to research this topic because I want to become a microbiologist in the
future. I am especially interested with the impact of Bifidobacterium longum/infantis on infants.
Outline:
Abstract
Keywords
Introduction
Topic 1
The impact of Bifidobacterium longum/infantis on infants’ gastrointestinal tract
- B. infantis is the only Bifidobacterium that can digest HMOs in human milk
- B. infantis reduce dysbiosis condition in infants
- B. infantis limit the colonization of other harmful bacteria in infant
Topic 2
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ABSTRACT
This review focuses on the impact of Bifidobacterium longum/infantis on infants and to
associate these impacts to effect of B. longum/infantis on the titers of polio IgA in infants.
Bifidobacterium longum/infantis is a ubiquitous inhabitant of the gastrointestinal tract of infants;
these bacteria are the champion colonizer of the gastrointestinal tract blocking out other harmful
bacteria from colonizing. B. longum/infantis have been shown to improve dysbiosis condition
and prevent infants from getting any allergy or harmful disease such as poliomyelitis. This
review was aimed to assess the impact B. longum/B. infantis has on infants and to associate these
impacts to the effect B. longum/B. infantis has on polio titers after vaccination. Researchers have
determined that infants who were fed with a fermented formula versus infants who were fed with
a placebo that the B. longum/B. infantis that was present in the stool of the infants was
significantly different from the placebo group (0.0399, fisher exact test). There is a positive
correlation between B. longum/B. infantis with anti-poliovirus.

Keywords
Bifidobacterium longum
Bifidobacterium infantis
Poliomyelitis
Human Milk Oligosaccharides- HMOs
Immunoglobulin
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INTRODUCTION
Bifidobacterium, member of the Actinobacteria phylum, is a genus of gram-positive bacteria
that is anaerobic and a ubiquitous inhabitant of the gastrointestinal tract. B. longum subspecies
infantis is a species of bacteria within the genus of Bifidobacterium that is found in the
microbiota of infant’s gastrointestinal tract and is associated with health benefits for infants.
Infants that have high levels of B. longum/infantis in their system tend to have an enhance
immune response to viruses such as polio and tend to be a good component for human milk
degradation. Infants that was born through C-section tend to have less B. infantis in their system
and must rely on breast milk or fermented milk to obtain the bacteria that can help prevent
numerous illness in infant that is colonize by the bacteria. B. longum/infantis is prominent in
infants that is breast fed or fed with a fermented formula which coincide with the increase in
antibodies titers of polio viruses (2).
Infants that have lower levels of B. longum/infantis are more likely to suffer from allergies
and is more susceptible to infections (2,8). Interestingly, mothers with allergies have
significantly lower levels of several different species of Bifidobacterium in their breast milk (5).
Polio virus cases is steadily increased 5-10 percent in children in the United States. This review
focuses on the impact of Bifidobacterium longum/infantis on infants and to associate these
impacts to effect of B. longum/infantis on the titers of polio IgA in infants.
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The impact of Bifidobacterium longum/infantis on infants’
gastrointestinal tract
Bifidobacterium infantis is a subspecies of B. longum; this species of Bifidobacteria are
mainly found colonizing the gastrointestinal tract of infants, and the older infants get the lower
the levels of B. longum/B.infantis (2). This may be a result because B. longum/B.infantis plays a
very vital role in the breakdown of human milk (9). The older one gets the more their diet move
from solely consuming human milk to being more diverse. B. longum/B.infantis is a ubiquitous
inhabitant so they crowd the gastrointestinal tract of infants that can potentially block out other
harmful bacteria from colonizing the gastrointestinal tract (8). The presence of Bifidobacterium
longum/infantis in the gastrointestinal tract of infants will have positive impacts on the infant’s
gut microbiota.

B. infantis is the only Bifidobacterium that can digest HMOs in human milk
Human Milk Oligosaccharides (HMOs) is a solid component found in human breast milk.
HMOs are complex carbohydrates that infants cannot digest, because the human gut does not
have the required enzymes to cleave the linkage between HMO molecules (8). There was an
uncertainty of the importance of HMOs to infants, since humans cannot digest these molecules,
until studies linked these HMOs to B. infantis (8). B. infantis have a gene called HMO cluster 1
that allows it to grow on a medium that contains HMOs more than any other form of
Bifidobacteria (8), and can cleave HMOs and deconstruct human milk glycan (8). Underwood
and German (8) concluded that infants that were colonized by B. infantis not only can
deconstruct human milk, but can also out compete other Bifidobacteria and other pathogenic
bacteria in the gut lumen of breast-fed milk. Premature infants did not have any species of
5

Bifidobacteria, but had a diversity of other bacteria, and premature infants were more
susceptible to Necrotizing enterocolitis (NEC) which is a dysbiosis condition (8). Dysbiosis is
an imbalance between the type of organisms present in one’s natural microflora. Probiotics is
a possible treatment for premature infants, because it contains B. infantis and will decrease
NEC in infants (8).

B. infantis reduce dysbiosis condition in infants
Dysbiosis is a condition characterized by the imbalance between the bacteria that is good
for you and the bacteria that is bad for you. The development of infant’s gut microbiota at the
beginning stage of their life will play a vital role in the long-term health of the infant (8).
Probiotics has been a treatment option to correct the imbalance of bacteria in the body (8, 10).
It has proven that probiotics that have B. infantis would lead to persistent colonization of
infants that were breast fed, which will eventually change the composition of the gut
microbiota (8). Infants guts whose colonized by B. longum/B.infantis showed higher levels of
Antipoliovirus IgAs when vaccinated with polio virus (2). This may be a result of the fact that
B. infantis is a ubiquitous inhabitant crowding the gut microbiota blocking out other harmful
bacteria from colonizing. (Frese, 2017) In conclusion, infants fed with B. infantis had
increased levels of B. infantis in their gut microbiota and fecal microbiota. The infants that
were not fed with any probiotics did not have any Bifidobacteria growing in their microbiota
(10). Thirty days after infants were treated with B. infantis; the bacteria were still present in
the gut microbiota and was one of the major colonizers of the gut (10). This may be a result of
the gene that B. infantis have adapted to cleave HMOs, infants’ diet is mainly consisting of
milk and it has been proven no other species of Bifidobacterium can digest the HMOs. The
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presence of B. infantis have many positive impacts on infant’s gut microbiota, making it a
friendly bacterium; this is a bacterium that one would like their child to have.

B. infantis limit the colonization of other harmful bacteria in infant
Infants obtain B. longum/B.infantis when they are born through the vagina or skin when
being delivered via C-section. These bacteria are present in the gut microbiota of the infant after
delivery, but they are not activated. Breast milk activates the Bifidobacterium to start colonizing
the gastrointestinal tract of infants. B. longum/B.infantis can change the fecal component of
infants which will in turn prevent diarrhea (2). The levels of B. infantis are lower in infants that
are delivered via C-section since the infant would not be exposed to as much Bifidobacteria
through delivery (2). Babies from more developed countries experience more dysbiosis condition
than those babies from less developed countries. This might be explained because C-section
delivery is not common in underdeveloped countries, and most infants delivered vaginally will
be more exposed to Bifidobacterium longum/ infantis stabilizing the colonization of the gut
microbiota (2).
Higher levels of B. longum/B.infantis have a positive impact on infants; B. infantis is the
only species of Bifidobacterium that can digest HMOs which prove helpful in human milk
degradation and B. longum/B.infantis plays a vital role in treating NEC (8). Lower level of B.
longum/ infantis have a negative impact on infant’s gut microbiota, this is because other bacteria
may colonize the infants gut microbiota that may be harmful to the infant and infants that have
lower levels of B. longum/B.infantis are more susceptible of having dysbiosis condition (2, 8).
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The immunological response of high level of B.
longum/infantis to polio titers in infants
Poliomyelitis, also called polio, is a disease that can affect both adults and infants. Polio
viruses can enter the body through the mouth, by hands or other body parts that have come in
contact with the feces of someone who has the polio virus. In order to prevent from getting the
polio virus, a polio vaccine was created and is recommended and sometimes required. Infants
that are predominantly colonized by B. longum/B. infantis correlate with higher levels of polio
titers when vaccinated with the polio vaccine (2, 11). Stool from infants with high levels of polio
titers had higher levels of B. longum/B. infantis (2, 11). Higher levels of Bifidobacterium longum
subspecies infantis and also longum will have a positive association with polio titers in infants.

Bifidobacterium (especially B. longum subspecies infantis) increase response to
oral polio virus vaccine early in infant’s life.
Immunization prevent infants and adults from getting infectious diseases such as
poliomyelitis. Studies have analyzed the association between vaccine responses and levels of
bacteria find in infants’ stool. For example, another member of the Actinobacteria phylum have a
positive association with oral polio virus specific T-cell proliferation and oral polio virus specific
immunoglobulin G responses (11). Also, infants with higher Oral Polio Virus CD4 molecule
responder also had higher levels of B. longum/B. infantis (11). CD4 molecules are a type of Tcell helper; which are proteins on antibodies that come in contact with antigens to produce an
immune response when the body encounter an antigen. Infants with higher level of Oral Polio
Virus CD8 molecule responder also had higher-levels of B. longum (11). Interestingly, stools
from those infants with high Oral Polio Virus vaccine responses, were predominantly colonized
8

by B. longum subspecies infantis (11). This result, indicated that the gut composition of the
microbiota of infants may play a vital role in which the infant’s immune system may interact
with oral or parental vaccines, because high levels of B. longum/ B. infantis result in increased
immunological response to vaccines (11). In fact, infants that have a more diverse gut microbiota
(and less Bifidobacteria) have lower responses to vaccines and may suffer from systematic
inflammation (11).

Secretory IgA in breast milk protects newborns from all infection
Breast milk is said to protect newborns from infection (2). Infants obtain B. longum/ B.
infantis when they are born (2, 8), breast milk is what activates the bacteria. Once activated,
Bifidobacteria will colonize the infant’s gastrointestinal tract (2). Breast milk also contains
secretory immunoglobulin titers; which are antibodies that serve as the first line of defense
against antigens (2). Therefore, infants that were breast fed immune system prime sooner than
infants that were not breast fed. Colonization by Bifidobacteria, mainly B. longum/B. infantis,
can trigger an immune response in infants (2). In order to test if the gut microbiota can trigger an
immune response, there was a study carried out with inactivated poliovirus vaccine to determine
if there is an increase in the fecal immunoglobulin A titers before and after vaccination (2).
Infants were either fed with fermented formula or placebo. Both groups had an increase in the
levels of B. longum/B. infantis in the infant’s feces, but the group that was treated with the
fermented formula had higher levels than the placebo (2). There was also a correlation between
the increased polio specific intestinal antibody response to higher levels of B.longum/B.infantis
in infants that were fed with fermented formula (2). Infants that were fed with fermented formula
(FIF) have a higher level of fecal bifidobacterial the longer they were being treated, which may
result in those infants having an increase in the Anti-poliovirus IgA titers (2,11). Fermented
9

formula can trigger an Anti-poliovirus response which in turn favors intestinal Bifidobacteria in
infants (2).
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CONCLUSION
This review focuses on the impact of Bifidobacterium longum/infantis on infants and to
associate these impacts to effect of B. longum/infantis on the titers of polio IgA in infants. Based
on the results gathered from each peer-reviewed article it is safe to say Bifidobacterium
longum/infantis is a friendly bacterium that you would want your child to have. B. longum/B.
infantis helps protect infants from dysbiosis and diseases including poliomyelitis. B. infantis is
the only bacteria that can digest HMOs which is very crucial for infants. B. longum/B. infantis is
more prominent in infants and are associated with higher levels of polio IgA titers when
vaccinated with the polio vaccine; infants that have lower levels of anti-poliovirus titers also
have lower levels of B. longum/B. infantis in their feces. Furthermore, infants who have higher
levels of anti-poliovirus titers also have higher levels of B. longum/B. infantis in their feces,
which indicates that there is a positive correlation between anti-poliovirus IgA and B. longum/B.
infantis.
It was determined that higher levels of B. longum/infantis will be present in infants that were
fed with infant fermented formula and those infants also have a higher level of antipoliovirus
titers. I accept the results that were determined in the peer-reviewed and I believe that there will
be a positive correlation with antipoliovirus titers and the levels of B. longum/infantis in infants
that was fed with fermented formula.
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